Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Mango Consumption Improves Biomarkers for Inflammation in Inflammatory Bowel Disease Patients

NCT02227602 is registered in ClinicalTrials.gov with Texas A&M University as lead sponsor.

NCT NCT02227602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02227602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Mango Consumption Improves Biomarkers for Inflammation in Inflammatory Bowel Disease Patients
Lead sponsor
Texas A&M University
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2014
Completion date
March 31, 2018
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, intestinal diseases, ulcerative colitis